Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

39.63 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Feb 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,317,019
Open 39.63
Bid (Size) 38.66 (800)
Ask (Size) 38.67 (100)
Prev. Close 39.63
Today's Range 39.63 - 39.63
52wk Range 39.34 - 93.80
Shares Outstanding N/A
Dividend Yield 2.95%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Novo Nordisk To Cut Ozempic, Wegovy Prices By Up To 50%: Report ↗
According to a report by The Wall Street Journal, Ozempic and Wegovy prices will start at a list price of $675 a month, effective Jan. 1, 2027. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
NVO Stock Continues To Decline Pre-Market After Monday’s Crash Amid CagriSema Setback – But Tuesday Brings Some Hope From China ↗
Developed in partnership with United Laboratories International Holdings, Novo Nordisk said that UBT251 delivered up to 19.7% mean weight loss after 24 weeks in a phase 2 trial in China. 
Via Stocktwits

Performance

YTD
-24.4%
-24.4%
1 Month
-38.1%
-38.1%
3 Month
-11.9%
-11.9%
6 Month
-29.7%
-29.7%
1 Year
-56.3%
-56.3%

More News

Read More
News headline image
Got $5,000? Viking Therapeutics Might Be a Weight‑Loss Drug Moon Shot in the Making. ↗
Via The Motley Fool
News headline image
Stock Market Today, Feb. 23: Novo Nordisk Plunges 16% After Obesity Drug Falls Short ↗
Via The Motley Fool
Topics Stocks
News headline image
Stock Market Today, Feb. 23: Nvidia Earnings Loom as Tariff Concerns Drive Dow 800 Points Lower ↗
Via The Motley Fool
Topics Artificial Intelligence Government Stocks
News headline image
Novo Nordisk Shares Tumble 15.1% After CagriSema Fails to Topple Eli Lilly in Head-to-Head Trial
Via MarketMinute
Check out the stocks that are attracting the most attention and driving market activity. ↗
Via Chartmill
News headline image
Why Viking Therapeutics Stock Is Up More Than 9% Today ↗
Via The Motley Fool
News headline image
Novo Nordisk A/S Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – NVO
From The DJS Law Group
Via Business Wire
News headline image
Why Eli Lilly Stock Just Popped ↗
Via The Motley Fool
News headline image
Why Novo Nordisk Stock Just Crashed ↗
Via The Motley Fool
News headline image
High Volatility and Earnings Crossroads: A Deep Dive into Hims & Hers Health (HIMS) in 2026
Via Finterra
Topics Artificial Intelligence Intellectual Property Lawsuit
News headline image
NVO Investors Have Opportunity to Join Novo Nordisk A/S Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Eli Lilly Surges as Novo Nordisk’s "CagriSema" Stumbles in High-Stakes Obesity Head-to-Head
Via MarketMinute
News headline image
Novo Nordisk Shares Plunge 13% as Next-Gen Weight Loss Drug CagriSema Fails to Topple Eli Lilly in Landmark Trial
Via MarketMinute
Topics Earnings
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
1 Reason I'm Seriously Considering Novo Nordisk as a Buy‑and‑Never‑Sell Obesity Stock ↗
Via The Motley Fool
News headline image
3 Reasons Viking Therapeutics Stock Could 10X if Its Obesity Pipeline Succeeds ↗
Via The Motley Fool
News headline image
Why Is NVO Stock Falling Pre-Market Today? ↗
Via Stocktwits
Topics Government
News headline image
2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $200 ↗
Via The Motley Fool
News headline image
Hims & Hers in Free Fall: Why Analysts See Nearly 150% Upside ↗
Via MarketBeat
News headline image
Novo Nordisk Stock Investors Just Got Great News From Eli Lilly ↗
Via The Motley Fool
News headline image
Is Pfizer Stock the Only Big Pharma Name I'd Buy and Hold Through Any Market Crash? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
2 Innovative Biotech Stocks That May Climb 58% and 200%, According to Wall Street ↗
Via The Motley Fool
News headline image
Warning: This Skyrocketing Stock Has a Hidden Risk ↗
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 39.63
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 02/23/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.